Reduction and Exhausted Features of T Lymphocytes Under Serological Changes, and Prognostic Factors in COVID-19 Progression
Overview
Molecular Biology
Authors
Affiliations
Aims: Coronavirus disease 2019 (COVID-19) is a novel viral infection threatening worldwide health as currently there exists no effective treatment strategy and vaccination programs are not publicly available yet. T lymphocytes play an important role in antiviral defenses. However, T cell frequency and functionality may be affected during the disease.
Material And Methods: Total blood samples were collected from patients with mild and severe COVID-19, and the total lymphocyte number, as well as CD4+ and CD8 + T cells were assessed using flowcytometry. Besides, the expression of exhausted T cell markers was evaluated. The levels of proinflammatory cytokines were also investigated in the serum of all patients using enzyme-linked immunesorbent assay (ELISA). Finally, the obtained results were analyzed along with laboratory serological reports.
Results: COVID-19 patients showed lymphopenia and reduced CD4+ and CD8 + T cells, as well as high percentage of PD-1 expression by T cells, especially in severe cases. Serum secretion of TNF-α, IL-1β, and IL-2 receptor (IL-2R) were remarkably increased in patients with severe symptoms, as compared with healthy controls. Moreover, high levels of triglyceride (TG) and low density lipoprotein cholesterol (LDL-C), were correlated with the severity of the disease.
Conclusion: Reduced number and function of T cells were observed in COVID-19 patients, especially in severe patients. Meanwhile, the secretion of proinflammatory cytokines was increased as the disease developed. High level of serum IL-2R was also considered as a sign of lymphopenia. Additionally, hypercholesterolemia and hyperlipidemia could be important prognostic factors in determining the severity of the infection.
Chen C, Lin Y, Liu K, Huang C, Shih C, Lee Y Virol J. 2024; 21(1):288.
PMID: 39538233 PMC: 11562311. DOI: 10.1186/s12985-024-02529-1.
Liu Y, Zhang W, Sun M, Liang X, Wang L, Zhao J BMC Pulm Med. 2024; 24(1):515.
PMID: 39402509 PMC: 11476205. DOI: 10.1186/s12890-024-03333-x.
Liu Z, Petinrin O, Chen N, Toseef M, Liu F, Zhu Z BMC Infect Dis. 2024; 24(1):1099.
PMID: 39363208 PMC: 11451256. DOI: 10.1186/s12879-024-10000-3.
Shekarchi A, Hosseini L, Kamrani A, Alipourfard I, Soltani-Zangbar M, Akbari M Mol Biol Rep. 2024; 51(1):442.
PMID: 38520563 DOI: 10.1007/s11033-024-09370-3.
Wu J, Mao X, Liu X, Mao J, Yang X, Zhou X Hereditas. 2024; 161(1):7.
PMID: 38297377 PMC: 10829297. DOI: 10.1186/s41065-023-00307-7.